Global Prostate Cancer Market and Competitive Landscape – 2017

Best Price Guarantee	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450501

Best Price Guarantee
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450501

Global Prostate Cancer Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Prostate Cancer Market and Competitive Landscape – 2017, provides comprehensive insights into Prostate Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Prostate Cancer market size and drug sales. This research also provides insights into Prostate Cancer epidemiology and late stage pipeline.
The report is classified into twelve sections – Prostate Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Prostate Cancer pipeline insights covering late stage clinical trials pipeline; Prostate Cancer prevalence trends by countries; Prostate Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Prostate Cancer pipeline: Find out the drugs in clinical trials for Prostate Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Prostate Cancer epidemiology: Find out the prevalence of Prostate Cancer by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Prostate Cancer products: Identify key products marketed and prescribed for Prostate Cancer by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Prostate Cancer market size: Find out the market size for Prostate Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Prostate Cancer drug sales: Find out the sales of Prostate Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Prostate Cancer drugs sales forecast: Sales forecast for Prostate Cancer drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Prostate Cancer market share analysis: Find out the market shares of Prostate Cancer drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Prostate Cancer drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Prostate Cancer market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Prostate Cancer market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Prostate Cancer: Disease Overview: 1.1. Prostate Cancer Symptoms; 1.2. Prostate Cancer Etiology; 1.3. Prostate Cancer Diagnosis; 1.4. Prostate Cancer Treatment Options
2. Prostate Cancer Pipeline Insights: 2.1. Prostate Cancer Phase 3 Clinical Trials; 2.2. Prostate Cancer Phase 2 Clinical Trials; 2.3. Prostate Cancer Phase 1 Clinical Trials
3. Prostate Cancer Epidemiology Analysis
4. US Prostate Cancer Market Insights: 4.1. Marketed Products for Prostate Cancer in US; 4.2. US Prostate Cancer Market Size & Forecast; 4.3. US Prostate Cancer Product Sales Forecast; 4.4. US Prostate Cancer Market Share Analysis
5. Germany Prostate Cancer Market Insights: 5.1. Marketed Products for Prostate Cancer in Germany; 5.2. Germany Prostate Cancer Market Size & Forecast; 5.3. Germany Prostate Cancer Product Sales Forecast; 5.4. Germany Prostate Cancer Market Share Analysis
6. France Prostate Cancer Market Insights: 6.1. Marketed Products for Prostate Cancer in France; 6.2. France Prostate Cancer Market Size & Forecast; 6.3. France Prostate Cancer Product Sales Forecast; 6.4. France Prostate Cancer Market Share Analysis
7. Italy Prostate Cancer Market Insights: 7.1. Marketed Products for Prostate Cancer in Italy; 7.2. Italy Prostate Cancer Market Size & Forecast; 7.3. Italy Prostate Cancer Product Sales Forecast; 7.4. Italy Prostate Cancer Market Share Analysis
8. Spain Prostate Cancer Market Insights: 8.1. Marketed Products for Prostate Cancer in Spain; 8.2. Spain Prostate Cancer Market Size & Forecast; 8.3. Spain Prostate Cancer Product Sales Forecast; 8.4. Spain Prostate Cancer Market Share Analysis
9. UK Prostate Cancer Market Insights: 9.1. Marketed Products for Prostate Cancer in UK; 9.2. UK Prostate Cancer Market Size & Forecast; 9.3. UK Prostate Cancer Product Sales Forecast; 9.4. UK Prostate Cancer Market Share Analysis
10. Europe Prostate Cancer Market Insights: 10.1. Europe Prostate Cancer Market Size & Forecast; 10.2. Europe Prostate Cancer Product Sales Forecast; 10.3. Europe Prostate Cancer Market Share Analysis
11. Japan Prostate Cancer Market Insights: 11.1. Marketed Products for Prostate Cancer in Japan; 11.2. Japan Prostate Cancer Market Size & Forecast; 11.3. Japan Prostate Cancer Product Sales Forecast; 11.4. Japan Prostate Cancer Market Share Analysis
12. Global Prostate Cancer Market Insights: 12.1. Global Prostate Cancer Market Size & Forecast; 12.2. Global Prostate Cancer Product Sales Forecast; 12.3. Global Prostate Cancer Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Prostate Cancer Phase 3 Clinical Trials, Global, 2017; Table 2: Prostate Cancer Phase 2 Clinical Trials, Global, 2017; Table 3: Prostate Cancer Phase 1 Clinical Trials, Global, 2017; Table 4: Prostate Cancer Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Prostate Cancer in US, 2017; Table 6: US Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 8: US Prostate Cancer Market Trends, 2012 - 2021; Table 9: Marketed Products for Prostate Cancer in Germany, 2017; Table 10: Germany Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 12: Germany Prostate Cancer Market Trends, 2012 - 2021; Table 13: Marketed Products for Prostate Cancer in France, 2017; Table 14: France Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 16: France Prostate Cancer Market Trends, 2012 - 2021; Table 17: Marketed Products for Prostate Cancer in Italy, 2017; Table 18: Italy Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 20: Italy Prostate Cancer Market Trends, 2012 - 2021; Table 21: Marketed Products for Prostate Cancer in Spain, 2017; Table 22: Spain Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 24: Spain Prostate Cancer Market Trends, 2012 - 2021; Table 25: Marketed Products for Prostate Cancer in UK, 2017; Table 26: UK Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 28: UK Prostate Cancer Market Trends, 2012 - 2021; Table 29: Europe Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Prostate Cancer in Japan, 2017; Table 32: Japan Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Prostate Cancer Product Sales ($mn), 2012 - 2021; Table 34: Japan Prostate Cancer Market Trends, 2012 - 2021; Table 35: Global Prostate Cancer Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Prostate Cancer Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Prostate Cancer Pipeline by Phase (%), Global, 2017; Figure 2: Prostate Cancer Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 4: US Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 5: US Prostate Cancer Market Share by Products (%), 2016; Figure 6: US Prostate Cancer Market - Future Market Share (%), 2021; Figure 7: Germany Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 8: Germany Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 9: Germany Prostate Cancer Market Share by Products (%), 2016; Figure 10: Germany Prostate Cancer Market - Future Market Share (%), 2021; Figure 11: France Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 12: France Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 13: France Prostate Cancer Market Share by Products (%), 2016; Figure 14: France Prostate Cancer Market - Future Market Share (%), 2021; Figure 15: Italy Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 16: Italy Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 17: Italy Prostate Cancer Market Share by Products (%), 2016; Figure 18: Italy Prostate Cancer Market - Future Market Share (%), 2021; Figure 19: Spain Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 20: Spain Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 21: Spain Prostate Cancer Market Share by Products (%), 2016; Figure 22: Spain Prostate Cancer Market - Future Market Share (%), 2021; Figure 23: UK Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 24: UK Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 25: UK Prostate Cancer Market Share by Products (%), 2016; Figure 26: UK Prostate Cancer Market - Future Market Share (%), 2021; Figure 27: Europe Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 28: Europe Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 29: Europe Prostate Cancer Market Share by Products (%), 2016; Figure 30: Europe Prostate Cancer Market - Future Market Share (%), 2021; Figure 31: Japan Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 32: Japan Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 33: Japan Prostate Cancer Market Share by Products (%), 2016; Figure 34: Japan Prostate Cancer Market - Future Market Share (%), 2021; Figure 35: Global Prostate Cancer Market Size ($mn), 2012 - 2021; Figure 36: Global Prostate Cancer Product Sales ($mn), 2012 - 2021; Figure 37: Global Prostate Cancer Market Share by Products (%), 2016; Figure 38: Global Prostate Cancer Market - Future Market Share (%), 2021